AIP
FLGT icon

Ahrens Investment Partners’s Fulgent Genetics FLGT Stock Holding History

Ahrens Investment Partners’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50
Closed -$3K – 994
2022
Q1 		$3K Buy
+50
New +$3.29K ﹤0.01% 908

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ahrens Investment Partners's FLGT Position: Q2 2022 in Review

Ahrens Investment Partners sold out of Fulgent Genetics (FLGT) in Q2 2022, closing a stake of 50 shares — an estimated $3K sold.

Ahrens Investment Partners first reported a position in FLGT in Q1 2022 and held it in 1 quarter. The position peaked at $3K in Q1 2022. 262 funds tracked by Wall St. Rank hold FLGT as of Q2 2022.

  • Ahrens Investment Partners reported no remaining Fulgent Genetics position as of Q2 2022 after selling out during the quarter.
  • Ahrens Investment Partners sold 50 Fulgent Genetics shares in Q2 2022, an estimated $3K.
  • Ahrens Investment Partners first reported a position in Fulgent Genetics in Q1 2022 and held it in 1 quarter.
  • Ahrens Investment Partners's Fulgent Genetics position peaked at $3K in Q1 2022.
  • 262 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2022.

Based on Ahrens Investment Partners's 13F filing for Q2 2022, filed 2 Aug 2022.